Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma.
Hu G, Dasari S, Asmann YW, Greipp PT, Knudson RA, Benson HK, Li Y, Eckloff BW, Jen J, Link BK, Jiang L, Sidhu JS, Wellik LE, Witzig TE, Bennani NN, Cerhan JR, Boddicker RL, Feldman AL. Hu G, et al. Among authors: dasari s. Leukemia. 2018 Feb;32(2):565-569. doi: 10.1038/leu.2017.309. Epub 2017 Oct 13. Leukemia. 2018. PMID: 29026208 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 33140103
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma.
Abeykoon JP, Murray DL, Murray I, Jevremovic D, Otteson GE, Dispenzieri A, Arendt BK, Dasari S, Gertz M, Gonsalves WI, Kourelis TV, Muchtar E, Dingli D, Warsame R, Go RS, Lacy MQ, Leung N, Buadi F, Lin Y, Kyle RA, Rajkumar V, Kumar S, Kapoor P. Abeykoon JP, et al. Among authors: dasari s. Br J Haematol. 2021 Apr;193(2):380-385. doi: 10.1111/bjh.17195. Epub 2020 Nov 20. Br J Haematol. 2021. PMID: 33216966 Free article.
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Abeykoon JP, Wu X, Nowakowski KE, Dasari S, Paludo J, Weroha SJ, Hu C, Hou X, Sarkaria JN, Mladek AC, Phillips JL, Feldman AL, Ravindran A, King RL, Boysen J, Stenson MJ, Carr RM, Manske MK, Molina JR, Kapoor P, Parikh SA, Kumar S, Robinson SI, Yu J, Boughey JC, Wang L, Goetz MP, Couch FJ, Patnaik MM, Witzig TE. Abeykoon JP, et al. Among authors: dasari s. Blood. 2021 Jan 28;137(4):513-523. doi: 10.1182/blood.2020009013. Blood. 2021. PMID: 33507295 Free PMC article.
The significance of gradient expression of chromosome region maintenance protein 1 (exportin1) in large cell lymphoma.
Abeykoon JP, Hampel PJ, King RL, Wood AJ, Larson MC, Nowakowski KE, Zanwar SS, Dasari S, Ruan GJ, Ravindran A, Wellik LE, Paludo J, Link BK, Cerhan JR, Ansell SM, Nowakowski GS, Thompson CA, Maurer MJ, Wenzl K, Novak AJ, Wu X, Habermann TM, Witzig TE. Abeykoon JP, et al. Among authors: dasari s. Haematologica. 2021 Aug 1;106(8):2261-2264. doi: 10.3324/haematol.2020.278277. Haematologica. 2021. PMID: 33657788 Free PMC article. No abstract available.
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease.
Abeykoon JP, Lasho TL, Dasari S, Rech KL, Ranatunga WK, Manske MK, Tischer A, Ravindran A, Young JR, Tobin WO, Flanagan EP, Nowakowski KE, Ruan GJ, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Patnaik MM, Wu X, Witzig TE, Goyal G, Go RS; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Abeykoon JP, et al. Among authors: dasari s. Am J Hematol. 2022 Mar 1;97(3):293-302. doi: 10.1002/ajh.26441. Epub 2022 Jan 3. Am J Hematol. 2022. PMID: 34978715 Free PMC article.
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
Zanwar S, Abeykoon JP, Dasari S, Ravindran A, Young JR, Acosta-Medina AA, Rech KL, Schwartz J, Mangold A, Rosenthal A, Bennani NN, Shah MV, Morlote D, Goyal G, Go RS. Zanwar S, et al. Among authors: dasari s. Blood Cancer J. 2022 Jun 28;12(6):97. doi: 10.1038/s41408-022-00693-7. Blood Cancer J. 2022. PMID: 35764604 Free PMC article. No abstract available.
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status.
Abeykoon JP, Rech KL, Young JR, Ravindran A, Ruan GJ, Dasari S, Morlote DM, King RL, Rummage C, Zanwar S, Acosta-Medina AM, Tobin WO, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Witzig TE, Goyal G, Go RS; Mayo Clinic–University of Alabama at Birmingham Histiocytosis Working Group. Abeykoon JP, et al. Among authors: dasari s. JAMA Oncol. 2022 Dec 1;8(12):1816-1820. doi: 10.1001/jamaoncol.2022.4432. JAMA Oncol. 2022. PMID: 36201194 Free PMC article.
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.
Boddicker RL, Razidlo GL, Dasari S, Zeng Y, Hu G, Knudson RA, Greipp PT, Davila JI, Johnson SH, Porcher JC, Smadbeck JB, Eckloff BW, Billadeau DD, Kurtin PJ, McNiven MA, Link BK, Ansell SM, Cerhan JR, Asmann YW, Vasmatzis G, Feldman AL. Boddicker RL, et al. Among authors: dasari s. Blood. 2016 Sep 1;128(9):1234-45. doi: 10.1182/blood-2016-03-707141. Epub 2016 Jun 13. Blood. 2016. PMID: 27297792 Free PMC article. Clinical Trial.
615 results